Azithromycin & Resistance: Gut & Nasopharynx Trial

by Archynetys Health Desk
  • Keenan, J. D. et al. Azithromycin to reduce childhood mortality in sub-Saharan Africa. New Engl. J. Med. 3781583–1592 (2018).

    Article
    CAS
    PubMed
    PubMed Central

    Google Scholar

  • Keenan, J. D. et al. Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial. Lancet Glob Health 8e288–e295 (2020).

    Article
    PubMed
    PubMed Central

    Google Scholar

  • Keenan, J. D. et al. Longer-term assessment of azithromycin for reducing childhood mortality in Africa. New Engl. J. Med. 3802207–2214 (2019).

    Article
    CAS
    PubMed
    PubMed Central

    Google Scholar

  • Oldenburg, C. E. et al. Mass azithromycin distribution to prevent child mortality in Burkina Faso: the CHAT randomized clinical trial. JAMA 331482–490 (2024).

    Article
    CAS
    PubMed
    PubMed Central

    Google Scholar

  • O’Brien, K. S. et al. Azithromycin to reduce mortality—an adaptive cluster-randomized trial. New Engl. J. Med. 391699–709 (2024).

    Article
    PubMed

    Google Scholar

  • WHO Guideline on Mass Drug Administration of Azithromycin to Children Under Five Years of Age to Promote Child Survival (World Health Organization, 2020).

  • Kahn, R., Eyal, N., Sow, S. O. & Lipsitch, M. Mass drug administration of azithromycin: an analysis. Clin. Microbiol. Infect. 29326–331 (2023).

    Article
    CAS
    PubMed

    Google Scholar

  • Alasmar, A., Kong, A. C., So, A. D. & DeCamp, M. Ethical challenges in mass drug administration for reducing childhood mortality: a qualitative study. Infect. Dis. Poverty 1199 (2022).

    Article
    PubMed
    PubMed Central

    Google Scholar

  • WHO Policy Recommendation: Seasonal Malaria Chemoprevention (SMC) for Plasmodium falciparum Malaria Control in Highly Seasonal Transmission Areas of the Sahel Sub-region in Africa (World Health Organization, 2012).

  • Zhang, D. et al. Modulation of fecal microbiota and reductions in fecal antibiotic resistance genes (ARGs) driven by Weissella-fermented feed in growing pigs. Ecotoxicol. Environ. Saf. 285117044 (2024).

    Article
    CAS
    PubMed

    Google Scholar

  • Arzese, A. R., Tomasetig, L. & Botta, G. A. Detection of tetQ and ermF antibiotic resistance genes in Prevotella and Porphyromonas isolates from clinical specimens and resident microbiota of humans. J. Antimicrob. Chemother. 45577–582 (2000).

    Article
    CAS
    PubMed

    Google Scholar

  • Veloo , ACM , Bass , WH , Haan , FJ , Coco , J. & Rossen , JW Prevalence of antimicrobial resistance genes in Bacteroides spp. and Prevotella spp. Dutch clinical isolates. Clin. Microbiol. Infect. 251156.e1159–1156.e1113 (2019).

  • Matos, J. et al. Insights from Bacteroides species in children with type 1 diabetes. Microorganisms 91436 (2021).

    Article
    CAS
    PubMed
    PubMed Central

    Google Scholar

  • Doan, T. et al. Mass azithromycin distribution and community microbiome: a cluster-randomized trial. Open Forum Infect. Dis. 5ofy182 (2018).

  • Doan, T. et al. Macrolide resistance in MORDOR I—a cluster-randomized trial in Niger. New Engl. J. Med. 3802271–2273 (2019).

    Article
    PubMed
    PubMed Central

    Google Scholar

  • Doan, T. et al. Gut microbiome alteration in MORDOR I: a community-randomized trial of mass azithromycin distribution. Night. With. 251370–1376 (2019).

  • Doan, T. et al. Macrolide and nonmacrolide resistance with mass azithromycin distribution. New Engl. J. Med. 3831941–1950 (2020).

    Article
    CAS
    PubMed
    PubMed Central

    Google Scholar

  • Arzika, A. M. et al. Gut resistome of preschool children after prolonged mass azithromycin distribution: a cluster-randomized trial. Clin. Infect. Dis. 731292–1295 (2021).

    Article
    PubMed
    PubMed Central

    Google Scholar

  • Arzika, A. M. et al. Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: a sub-study of a cluster-randomized trial (MORDOR). PLoS Med. 21e1004386 (2024).

    Article
    CAS
    PubMed
    PubMed Central

    Google Scholar

  • Olesen, S. W., Lipsitch, M. & Grad, Y. H. The role of ‘spillover’ in antibiotic resistance. Proc. Natl Acad. Sci. USA 11729063–29068 (2020).

    Article
    CAS
    PubMed
    PubMed Central

    Google Scholar

  • Chung, W. O., Werckenthin, C., Schwarz, S. & Roberts, M. C. Host range of the ermF rRNA methylase gene in bacteria of human and animal origin. J. Antimicrob. Chemother. 435–14 (1999).

    Article
    CAS
    PubMed

    Google Scholar

  • Rasmussen, J. L., Odelson, D. A. & Macrina, F. L. Complete nucleotide sequence and transcription of ermF, a macrolide-lincosamide-streptogramin B resistance determinant from Bacteroides fragilis. J. Bacteriol. 168523–533 (1986).

    Article
    CAS
    PubMed
    PubMed Central

    Google Scholar

  • Arredondo, A., Blanc, V., Mor, C., Nart, J. & León, R. Azithromycin and erythromycin susceptibility and macrolide resistance genes in Prevotella from patients with periodontal disease. Oral Dis. 25860–867 (2019).

    Article
    PubMed

    Google Scholar

  • Rong, S. M. M., Rodloff, A. C. & Stingu, C.-S. Diversity of antimicrobial resistance genes in Bacteroides and Parabacteroides strains isolated in Germany. J. Glob. Antimicrob. Resist. 24328–334 (2021).

    Article
    CAS
    PubMed

    Google Scholar

  • Eitel, Z., Sóki, J., Urbán, E. & Nagy, E. The prevalence of antibiotic resistance genes in Bacteroides fragilis group strains isolated in different European countries. Anaerobic 2143–49 (2013).

  • Wexler, H. M. Bacteroides: the good, the bad, and the nitty-gritty. Clin. Microbiol. Rev. 20593–621 (2007).

    Article
    CAS
    PubMed
    PubMed Central

    Google Scholar

  • Sherrard, L. et al. Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patients. J. Antimicrob. Chemother. 692690–2698 (2014).

  • Kajihara, T. et al. Distribution, trends, and antimicrobial susceptibility of Bacteroides,Clostridium, Fusobacteriumand Prevotella species causing bacteremia in Japan during 2011–2020: a retrospective observational study based on national surveillance data. Open Forum Infect. Dis. 10ofad334 (2023).

    Article
    PubMed
    PubMed Central

    Google Scholar

  • Bloom, S. M. et al. Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe 9390–403 (2011).

    Article
    CAS
    PubMed
    PubMed Central

    Google Scholar

  • Wilkins, L. J., Monga, M. & Miller, A. W. Defining dysbiosis for a cluster of chronic diseases. Sci. Rep. 912918 (2019).

    Article
    PubMed
    PubMed Central

    Google Scholar

  • Chung, W. O., Young, K., Leng, Z. & Roberts, M. C. Mobile elements carrying ermF and tetQ genes in gram-positive and gram-negative bacteria. J. Antimicrob. Chemother. 44329–335 (1999).

    Article
    CAS
    PubMed

    Google Scholar

  • Poirel, L. et al. Antimicrobial resistance in Escherichia coli. Microbiol. Spectr. https://doi.org/10.1128/microbiolspec.arba-0026-2017 (2018).

  • Phuc Nguyen, MC et al. Escherichia coli as reservoir for macrolide resistance genes. Emerg. Infect. Dis. 151648–1650 (2009).

    Article
    PubMed
    PubMed Central

    Google Scholar

  • Nguyen, M. & Vedantam, G. Mobile genetic elements in the genus Bacteroidesand their mechanism(s) of dissemination. Mob. Genet. Elements 1187–196 (2011).

    Article
    PubMed
    PubMed Central

    Google Scholar

  • Lawson, P. A. & Tanner, R. S. Cultivation of anaerobic bacteria: foundations and principles. Anaerobic 93102951 (2025).

    Article
    CAS
    PubMed

    Google Scholar

  • Hazel, A. et al. Temporal trends in phenotypic macrolide and nonmacrolide resistance for Streptococcus pneumoniae nasopharyngeal samples up to 36 months after mass azithromycin administration in a cluster-randomized trial in Niger. Am. J. Trop. Medi. Hyg. 1091107–1112 (2023).

  • Conrads, G. et al. The antimicrobial susceptibility of Porphyromonas gingivalis: genetic repertoire, global phenotype, and review of the literature. Antibiotics 101438 (2021).

    Article
    CAS
    PubMed
    PubMed Central

    Google Scholar

  • Castillo, Y. et al. Antibiotic susceptibility and resistance genes in oral clinical isolates of Prevotella intermedia, Prevotella blackishand Prevotella melaninogenica. Antibiotics 11888 (2022).

    Article
    CAS
    PubMed
    PubMed Central

    Google Scholar

  • Rams, T. E., Sautter, J. D. & van Winkelhoff, A. J. Emergence of antibiotic-resistant Porphyromonas gingivalis in United States periodontitis patients. Antibiotics 121584 (2023).

    Article
    CAS
    PubMed
    PubMed Central

    Google Scholar

  • Sanai, Y. et al. Presence and antibiotic resistance of Porphyromonas gingivalis, Prevotella intermediaand Prevotella blackish in children. J. Clin. Periodontol. 29929–934 (2002).

    Article
    PubMed

    Google Scholar

  • Pechère, J. C. Macrolide resistance mechanisms in Gram-positive cocci. Int. J. Antimicrob. Agents 1825–28 (2001).

    Article

    Google Scholar

  • Mack, I. et al. Antimicrobial resistance following azithromycin mass drug administration: potential surveillance strategies to assess public health impact. Clin. Infect. Dis. 701501–1508 (2020).

    Article
    CAS
    PubMed
    PubMed Central

    Google Scholar

  • Hassall, J., Coxon, C., Patel, V. C., Goldenberg, S. D. & Sergaki, C. Limitations of current techniques in clinical antimicrobial resistance diagnosis: examples and future prospects. npj Antimicrob. Resist. 216 (2024).

    Article
    CAS
    PubMed
    PubMed Central

    Google Scholar

  • Uzan-Yulzari, A. et al. Neonatal antibiotic exposure impairs child growth during the first six years of life by perturbing intestinal microbial colonization. Nat. Common. 12443 (2021).

    Article
    CAS
    PubMed
    PubMed Central

    Google Scholar

  • Cox, L. M. et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158705–721 (2014).

    Article
    CAS
    PubMed
    PubMed Central

    Google Scholar

  • Marra, F. et al. Antibiotic use in children is associated with increased risk of asthma. Pediatrics 1231003–1010 (2009).

    Article
    PubMed

    Google Scholar

  • Korpela, K. et al. Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nat. Common. 710410 (2016).

    Article
    CAS
    PubMed
    PubMed Central

    Google Scholar

  • Gensollen, T., Iyer, S. S., Kasper, D. L. & Blumberg, R. S. How colonization by microbiota in early life shapes the immune system. Science 352539–544 (2016).

    Article
    CAS
    PubMed
    PubMed Central

    Google Scholar

  • Nobel, Y. R. et al. Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment. Nat. Common. 67486 (2015).

    Article
    PubMed
    PubMed Central

    Google Scholar

  • Blaser, M. J. & Dominguez-Bello, M. G. The invisible extinction. Ann. Rev. Microbiol. 79311–334 (2025).

    Article
    CAS

    Google Scholar

  • Ray, K. J. et al. High-throughput sequencing of pooled samples to determine community-level microbiome diversity. Ann. Epidemiol 3963–68 (2019).

    Article
    PubMed
    PubMed Central

    Google Scholar

  • Agustinho, D. P. et al. Unveiling microbial diversity: harnessing long-read sequencing technology. Nat. Methods 21954–966 (2024).

    Article
    CAS
    PubMed
    PubMed Central

    Google Scholar

  • Cheng, M. et al. Deep longitudinal lower respiratory tract microbiome profiling reveals genome-resolved functional and evolutionary dynamics in critical illness. Nat. Common. 158361 (2024).

    Article
    PubMed
    PubMed Central

    Google Scholar

  • Wu, H. et al. Longitudinal analyses of infants’ microbiome and metabolome reveal microbes and metabolites with seemingly coordinated dynamics. Commun. Biol. 71506 (2024).

    Article
    CAS
    PubMed
    PubMed Central

    Google Scholar

  • Jia, B. et al. CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database. Nucleic Acids Res. 45D566–D573 (2017).

    Article
    CAS
    PubMed

    Google Scholar

  • Zankari, E. et al. Identification of acquired antimicrobial resistance genes. J. Antimicrob. Chemother. 672640–2644 (2012).

    Article
    CAS
    PubMed
    PubMed Central

    Google Scholar

  • Quan, J. et al. FLASH: a next-generation CRISPR diagnostic for multiplexed detection of antimicrobial resistance sequences. Nucleic Acids Res. 47e83 (2019).

    Article
    CAS
    PubMed
    PubMed Central

    Google Scholar

  • Lakin, S. M. et al. MEGARes: an antimicrobial resistance database for high throughput sequencing. Nucleic Acids Res. 45D574–D580 (2017).

    Article
    CAS
    PubMed

    Google Scholar

  • Bonin, N. et al. MEGARes and AMR++, v3.0: an updated comprehensive database of antimicrobial resistance determinants and an improved software pipeline for classification using high-throughput sequencing. Nucleic Acids Res. 51D744–D752 (2023).

    Article
    CAS
    PubMed
    PubMed Central

    Google Scholar

  • Liu, Y., Ghaffari, M. H., Ma, T. & Tu, Y. Impact of database choice and confidence score on the performance of taxonomic classification using Kraken 2. aBIOTECH 5465–475 (2024).

    Article
    CAS
    PubMed
    PubMed Central

    Google Scholar

  • Wood, D. E., Lu, J. & Langmead, B. Improved metagenomic analysis with Kraken 2. Genome Biol. 20257 (2019).

    Article
    CAS
    PubMed
    PubMed Central

    Google Scholar

  • Lu, J., Breitwieser, F. P., Thielen, P. & Salzberg, S. L. Bracken: estimating species abundance in metagenomics data. PeerJ Comput. Sci. 3e104 (2017).

    Article
    PubMed
    PubMed Central

    Google Scholar

  • Oksanen, J. vegan: Community ecology package. R version 4.3.1 (2024).

  • Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15550 (2014).

    Article
    PubMed
    PubMed Central

    Google Scholar

  • Harrison, P. F., Pattison, A. D., Powell, D. R. & Beilharz, T. H. Topconfects: a package for confident effect sizes in differential expression analysis provides a more biologically useful ranked gene list. Genome Biol. 2067 (2019).

    Article
    PubMed
    PubMed Central

    Google Scholar

  • Doan, T. et al. Supplementary data for “Effect of mass azithromycin distribution on antibiotic resistance in the gut and nasopharynx: a cluster-randomized trial”. Dryad https://doi.org/10.5061/dryad.p8cz8wb48 (2026).

  • Related Posts

    Leave a Comment